How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

How We Manage Patients With Chronic Lymphocytic Leukemia During the SARS-CoV-2 Pandemic

Abstract. Infections are a major cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL). These can be exacerbated by anti-leukemic treatments. In addition, the typical patients with CLL already have fragilities and background risk factors that apply to the general popul...

Full description

Bibliographic Details
Main Authors: Davide Rossi, Mazyar Shadman, Adalgisa Condoluci, Jennifer R. Brown, John C. Byrd, Gianluca Gaidano, Michael Hallek, Peter Hillmen, Anthony Mato, Emili Montserrat, Paolo Ghia
Format: Article
Language:English
Published: Wolters Kluwer 2020-08-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000432

Internet

http://journals.lww.com/10.1097/HS9.0000000000000432

Similar Items